Oral pharmaceutical dosage forms comprising a proton pump...

Details Oral pharmaceutical dosage forms comprising a proton pump... Oral pharmaceutical dosage forms comprising a proton pump...

2003-07-14

2009-02-10

Channavajjala, Lakshmi S (Department: 1611)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S464000, C424S470000, C424S471000

Reexamination Certificate

active

07488497

ABSTRACT:
An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.

REFERENCES:
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 5417980 (1995-05-01), Goldman et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5582837 (1996-12-01), Shell
patent: 5651987 (1997-07-01), Fuisz
patent: 5753265 (1998-05-01), Bergstrand et al.
patent: 5763422 (1998-06-01), Lichtenberger et al.
patent: 5817338 (1998-10-01), Bergstrand et al.
patent: 5955451 (1999-09-01), Lichtenberger et al.
patent: 6136344 (2000-10-01), Depui et al.
patent: 6365184 (2002-04-01), DePui et al.
patent: 6613354 (2003-09-01), Depui et al.
patent: 0008780 (1979-08-01), None
patent: 0072021 (1982-08-01), None
patent: 0080341 (1982-11-01), None
patent: 0108295 (1983-10-01), None
patent: 0108504 (1983-10-01), None
patent: 0111103 (1983-10-01), None
patent: 0170752 (1984-12-01), None
patent: 0247983 (1987-12-01), None
patent: 0013566 (1990-01-01), None
patent: 0391518 (1990-02-01), None
patent: 0365947 (1990-05-01), None
patent: 0426479 (1990-05-01), None
patent: 0541369 (1992-11-01), None
patent: 0587220 (1993-08-01), None
patent: 0648487 (1994-10-01), None
patent: 2066070 (1980-12-01), None
patent: 2091097 (1981-11-01), None
patent: 2132887 (1983-11-01), None
patent: 2285989 (1995-01-01), None
patent: 08-301763 (1996-11-01), None
patent: 8501207 (1984-09-01), None
patent: 8503436 (1985-02-01), None
patent: 8702240 (1986-09-01), None
patent: 9312772 (1992-12-01), None
patent: 9403160 (1993-07-01), None
patent: 9404484 (1994-03-01), None
patent: 9412463 (1994-06-01), None
patent: 9509831 (1995-04-01), None
patent: 9510264 (1995-04-01), None
patent: 9530641 (1995-11-01), None
patent: 9725064 (1997-07-01), None
patent: 9822117 (1998-05-01), None
patent: 9822118 (1998-05-01), None
patent: 0166087 (2001-09-01), None
patent: 0222108 (2002-03-01), None
McCarthy, D.M. 1989 Gastroenterology 96:662-674, “Nonsteroidal Antiinflammatory Drug-Induced Ulcers . . . ”.
Walan, A. Et al. 1989 “Effect of omeprazole and ranitine on ulcer healing . . . ” The N.E. J. Med 320:69.
Guess, H.A. et al. 1988 “Fatal upper gastrointestinal hemorrhage or perforation . . . ” J. Clin. Epidimol 41:35-45.
Larkai, E.N. et al. 1987 “Gastroduodenal mucosa and dyspeptic symptoms . . . ” Am. J. Gastroenterology 82:1153.
Catford, J.C. et al. 1986 “Confidential inquiry into deaths from peptic ulcer . . . ” Health Trends 18:37-41.
Hawkey C. “Non-steroidal anti-inflammatory drugs and peptic ulcers . . . ” (1990) 300:278-284.
Scheiman, J.M. “Pathogenesis of gastroduodenal injury . . . ” (1982) Semin. Arthritis Reheum. 21(4):201-210-.
Drug Facts and Comparisons 1994, pp. 1679-1684.
Remington: The Science and Practice of Pharmacy, chapter 93, 1650-1656, 1995.
Wan, L.S.C., “A Multiple-unit Tablet Formulation for Multi-layer Drug-coated Granules”, S.T.P. PHARMA Sciences, 4(5)(1994), pp. 336-342.
Chem. Pharm. Bull., 42(11), 2327-2331 (1994).
Chem. Pharm. Bull., 44(7), 1361-1366 (1996).

Affiliated with

Also associated with

Rating

Oral pharmaceutical dosage forms comprising a proton pump... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral pharmaceutical dosage forms comprising a proton pump..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical dosage forms comprising a proton pump... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4100691